Involvement of the Nervous System in SARS-CoV-2 Infection.

Hao Li, Qun Xue, Xingshun Xu
Author Information
  1. Hao Li: Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu, China.
  2. Qun Xue: Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu, China. qxue_sz@163.com.
  3. Xingshun Xu: Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu, China. xingshunxu@suda.edu.cn. ORCID

Abstract

As a severe and highly contagious infectious disease, coronavirus disease 2019 (COVID-19) has caused a global pandemic. Several case reports have demonstrated that the respiratory system is the main target in patients with COVID-19, but the disease is not limited to the respiratory system. Case analysis indicated that the nervous system can be invaded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that 36.4% of COVID-19 patients had neurological symptoms. Importantly, the involvement of the CNS may be associated with poor prognosis and disease worsening. Here, we discussed the symptoms and evidence of nervous system involvement (directly and indirectly) caused by SARS-CoV-2 infection and possible mechanisms. CNS symptoms could be a potential indicator of poor prognosis; therefore, the prevention and treatment of CNS symptoms are also crucial for the recovery of COVID-19 patients.

Keywords

References

  1. J Med Virol. 2020 Jun;92(6):552-555 [PMID: 32104915]
  2. Emerg Microbes Infect. 2020 Dec;9(1):221-236 [PMID: 31987001]
  3. Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):316-7 [PMID: 19555790]
  4. BMJ. 2020 Feb 19;368:m606 [PMID: 32075786]
  5. Cell Rep. 2018 Dec 11;25(11):3194-3203.e4 [PMID: 30540950]
  6. Epigenomics. 2016 Nov;8(11):1553-1569 [PMID: 27686106]
  7. Int J Infect Dis. 2020 May;94:55-58 [PMID: 32251791]
  8. Nat Microbiol. 2020 Apr;5(4):536-544 [PMID: 32123347]
  9. Turk J Med Sci. 2020 Apr 17;50(SI-1):563-570 [PMID: 32299206]
  10. Trends Pharmacol Sci. 2016 Dec;37(12):1045-1054 [PMID: 27717506]
  11. Allergy. 2020 Jul;75(7):1730-1741 [PMID: 32077115]
  12. Cell. 2020 Apr 16;181(2):271-280.e8 [PMID: 32142651]
  13. Lancet Psychiatry. 2020 Apr;7(4):e15-e16 [PMID: 32085839]
  14. Med Sci Monit. 2020 Mar 05;26:e923549 [PMID: 32132521]
  15. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  16. J Virol. 1999 Apr;73(4):3338-50 [PMID: 10074188]
  17. MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):140-146 [PMID: 32027631]
  18. Endocr Rev. 1998 Jun;19(3):269-301 [PMID: 9626555]
  19. JAMA. 2020 Mar 17;323(11):1061-1069 [PMID: 32031570]
  20. J Virol. 2015 Oct;89(19):9896-908 [PMID: 26202229]
  21. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):147-157 [PMID: 32391658]
  22. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Mar 20;38(3):192-195 [PMID: 32131151]
  23. FEBS Lett. 2018 Jan;592(1):5-14 [PMID: 29223133]
  24. Psychoneuroendocrinology. 2018 Jul;93:8-19 [PMID: 29680774]
  25. Biosci Trends. 2020 Mar 16;14(1):72-73 [PMID: 32074550]
  26. Clin Immunol. 2019 Oct;207:97-99 [PMID: 31454696]
  27. Lancet Psychiatry. 2020 Apr;7(4):300-302 [PMID: 32085840]
  28. Int J Antimicrob Agents. 2020 Mar;55(3):105924 [PMID: 32081636]
  29. Adv Exp Med Biol. 2014;807:75-96 [PMID: 24619619]
  30. Acta Pharm Sin B. 2020 Mar;10(3):383-398 [PMID: 32140387]
  31. J Pharm Bioallied Sci. 2013 Apr;5(2):91-7 [PMID: 23833514]
  32. Lancet. 2020 Feb 22;395(10224):e37-e38 [PMID: 32043982]
  33. Viral Immunol. 2019 Jan/Feb;32(1):25-37 [PMID: 30109979]
  34. J Immunol. 1998 Jun 1;160(11):5441-7 [PMID: 9605146]
  35. RSC Adv. 2019 Aug 8;9(42):24568-24594 [PMID: 35527877]
  36. J Pathol. 2004 Jun;203(2):622-30 [PMID: 15141376]
  37. Antiviral Res. 2019 Jul;167:45-67 [PMID: 30974127]
  38. J Pathol. 2004 Jun;203(2):631-7 [PMID: 15141377]
  39. Mol Neurodegener. 2017 Jun 21;12(1):49 [PMID: 28633663]
  40. Lancet Psychiatry. 2020 Mar;7(3):e14 [PMID: 32035030]
  41. Clin Exp Immunol. 2018 Jul;193(1):3-12 [PMID: 29328507]
  42. J Virol. 2018 Aug 16;92(17): [PMID: 29925652]
  43. Compr Physiol. 2016 Mar 15;6(2):603-21 [PMID: 27065163]
  44. Nat Rev Immunol. 2005 Mar;5(3):243-51 [PMID: 15738954]
  45. J Med Virol. 2005 Sep;77(1):1-7 [PMID: 16032747]
  46. Clin Exp Immunol. 2005 Sep;141(3):500-8 [PMID: 16045740]
  47. Adv Exp Med Biol. 2019;1180:147-178 [PMID: 31784962]
  48. Emerg Infect Dis. 2020 May;26(5):1052-1054 [PMID: 32091386]
  49. N Engl J Med. 2020 Mar 19;382(12):1177-1179 [PMID: 32074444]
  50. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  51. Int J Infect Dis. 2020 Apr;93:205-207 [PMID: 32142979]
  52. JAMA Netw Open. 2020 Mar 2;3(3):e203976 [PMID: 32202646]
  53. Lancet. 2020 Feb 15;395(10223):507-513 [PMID: 32007143]
  54. J Neurovirol. 2010 Nov;16(6):427-34 [PMID: 21073281]
  55. J Med Virol. 2020 May;92(5):479-490 [PMID: 32052466]
  56. Brain Behav Immun. 2009 May;23(4):535-47 [PMID: 19217938]
  57. Ann Neurol. 2018 Jan;83(1):166-177 [PMID: 29293273]
  58. JAMA Neurol. 2020 Jun 1;77(6):683-690 [PMID: 32275288]
  59. Nature. 2020 Mar;579(7798):265-269 [PMID: 32015508]

Grants

  1. 2017YFE0103700/National Key R&D Program of China

MeSH Term

Angiotensin-Converting Enzyme 2
Betacoronavirus
COVID-19
Cerebrovascular Disorders
Combined Modality Therapy
Consciousness Disorders
Coronavirus Infections
Dizziness
Encephalitis, Viral
Endothelial Cells
Fatigue
Headache
Humans
Intracranial Hypertension
Mental Disorders
Mood Disorders
Nervous System Diseases
Neurons
Olfactory Nerve
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
Prevalence
Prognosis
Psychotherapy
Psychotropic Drugs
Receptors, Virus
Retrospective Studies
SARS-CoV-2
Sensation Disorders
Spike Glycoprotein, Coronavirus

Chemicals

Psychotropic Drugs
Receptors, Virus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Peptidyl-Dipeptidase A
ACE2 protein, human
Angiotensin-Converting Enzyme 2

Word Cloud

Created with Highcharts 10.0.0COVID-19systemdiseaseSARS-CoV-2symptomsrespiratorypatientsnervousCNSseverecoronaviruscausedinvolvementpoorprognosisInfectionhighlycontagiousinfectious2019globalpandemicSeveralcasereportsdemonstratedmaintargetlimitedCaseanalysisindicatedcaninvadedacutesyndrome2364%neurologicalImportantlymayassociatedworseningdiscussedevidencedirectlyindirectlyinfectionpossiblemechanismspotentialindicatorthereforepreventiontreatmentalsocrucialrecoveryInvolvementNervousSystemCentral

Similar Articles

Cited By